Morgan Stanley Maintains Underweight on Doximity, Raises Price Target to $25
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Underweight rating on Doximity (NYSE:DOCS) and raises the price target from $21 to $25.
November 10, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley maintains an Underweight rating on Doximity, but raises the price target from $21 to $25.
The news is directly related to Doximity (DOCS). While the Underweight rating suggests that Morgan Stanley expects the stock to underperform, the increase in price target from $21 to $25 indicates a more positive outlook than before. This mixed signal could lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100